IL17A and atherosclerosis: And steroid hormone biosynthesis metabolism, arachidonic acid metabolism, linoleic acid metabolism, PI3K-Akt signaling pathway, lipid and atherosclerosis, IL-17 signaling pathway, relaxin signaling pathway may be potential therapeutic mechanisms of GGD for CHD.